1. Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys

   • Erika Cretton-Scott
   • Laurent Placidi
   • Jean-Pierre Sommadossi

   ORIGINAL ARTICLE Pages: 117 - 122

2. Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft

   • G. Pratesi
   • Michelandrea De Cesare
   • Franco Zunino

   ORIGINAL ARTICLE Pages: 123 - 128

3. Pharmacokinetics and toxicity of oral and intravenous lonidamine in dogs

   • G. S. Price
   • Rodney L. Page
   • D. E. Thrall

   ORIGINAL ARTICLE Pages: 129 - 135

4. A convenient tubulin-based quantitative assay for paclitaxel (Taxol) derivatives more effective in inducing assembly than the parent compound

   • Chii M. Lin
   • Yuan Q. Jiang
   • E. Hamel

   ORIGINAL ARTICLE Pages: 136 - 140

5. Effect of the exposure dose of etoposide on the cell growth and cell kinetics of human ovarian cancer cells

   • Yuji Ohishi
   • K. Fujiwara
   • Ichiro Kohno

   ORIGINAL ARTICLE Pages: 141 - 146

6. Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration

   • A. V. Boddy
   • S. Murray Yule
   • Jeffrey R. Idle

   ORIGINAL ARTICLE Pages: 147 - 154

7. Biotransformation of the platinum drug JM216 following oral administration to cancer patients

   • F. I. Raynaud
   • P. Mistry
   • K. R. Harrap

   ORIGINAL ARTICLE Pages: 155 - 162

8. Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin

   • Jonathan E. Cryer
   • Steven W. Johnson
   • P. C. Billings

   ORIGINAL ARTICLE Pages: 163 - 168

9. Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

   • B. A. Teicher
   • Sylvia A. Holden
   • Krishna Menon

   ORIGINAL ARTICLE Pages: 169 - 177

10. Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias

    • W. R. Waud
    • Karen S. Gilbert
    • John F. Worzalla

    ORIGINAL ARTICLE Pages: 178 - 180

11. Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing

    • L.-B. Lan
    • Suhail Ayesh
    • W. D. Stein

    ORIGINAL ARTICLE Pages: 181 - 190

12. Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen

    • J. Feliu
    • M. Gonzáles Barón
    • ONCOPAZ Cooperative Group

    CLINICAL TRIAL REPORT Pages: 191 - 194

13. 5-Methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil’s cytotoxic activity in vivo? A phase II study in patients with advanced colon cancer

    • C. Porta
    • Mauro Moroni
    • Giuseppe Nastasi

    CLINICAL TRIAL REPORT Pages: 195 - 197

14. Comparison of the uptake of retinoids 13-cis-retinoic acid and Ro 13-6298 delivered to HL-60 cells by serum albumin or low-density lipoprotein

    • R. Mouawad
    • Saïk Urien
    • Gérard Bastian

    SHORT COMMUNICATION Pages: 198 - 201